Affimed N.V. Gross Profit

The latest gross profit for AFMD is $880K as of September 2024. That compares with $19M in the prior-year period — down 95.4% year over year. That is below the Healthcare sector average of $65B. Investors often review this figure alongside Affimed N.V.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, AFMD's gross profit moved from $19M to $880K — a 95.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Affimed N.V.'s operating scale or balance-sheet position.

Against Healthcare companies, AFMD currently prints $880K for gross profit, while the sector average sits near $65B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Affimed N.V.'s growth, margins, and balance sheet.

A gross profit figure of $880K for AFMD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $65B. Explore the charts below for those layers of context.

After noting AFMD's gross profit ($880K), review year-over-year change from $19M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.